Skip to content
Smart Scholars🛡 Scholar Shield🏛 Research Integrity Desk🧩 Portfolio Console📰 Journals🔧 DOI MembersTools🔎 Journal AuditGI GetIndexedDr DOI Doctor

10.46243/jst.2021.v6.i2.pp01-08 registered

Review on Nanotechnology persecute vital role of Curative Applications in Medicinal Field and its ailing Effects

Resolves to https://www.jst.org.in/index.php/pub/article/view/356

Held by Longman Publishers (India) · prefix 10.46243 live · DOI address https://doi.org/10.46243/jst.2021.v6.i2.pp01-08

Registered 29 Sep 2026 via crossref · record version 2 · last change 29 Sep 2026, 11:59 PM · record sha256 cfdd01325a028e5d…

Resolve ⬇ Record (JSON) ⬇ Kernel Metadata Declaration (XML) Compare with Crossref Cite (APA · BibTeX · RIS · CSL)

Also as schema.org JSON-LD · Turtle · RDF/XML · DataCite XML · Crossref UNIXREF · Crossref UNIXSD — the formats of the DOI content-negotiation service, from this record (which carries what).

What the DOI identifies

JournalArticle — an article in a journal · Digital · Visual · en

Review on Nanotechnology persecute vital role of Curative Applications in Medicinal Field and its ailing Effects (PrincipalTitle · en)

Published 2021-02-02

Part of Journal of Science & Technology · ISSN 2456-5660 · volume 06 · issue 02 · pages 01–08

Agents

Identifiers DOI 10.46243/jst.2021.v6.i2.pp01-08

Abstract · en

Nowadays, nanotechnology impacts human life every day, and the potential benefits are many and various. In contrast, due to extensive human exposure to nanoparticles, there is an important concern about the potential health and environmental risks. These concerns led to the emergence of further scientific disciplines such as nanotoxicology and nanomedicine. Nanotoxicology which is interesting in the study of potential adverse health effects of nanoparticles.While, Nanomedicine, which includes subsectors such as tissue biomaterials, engineering, biosensors, and bioimaging, was developed to study the benefits and hazards of nanomaterials that are used in medicine andmedical devices.In addition, a key promise of nanotechnology is for improved healthcare, including potentiallyrevolutionary treatments for cancer diseases (detection of cancer cells at the early stage) and improved drug delivery (such as reducing side effects), reduced inflammation, antibacterial coverings of medical devices, better surgical tissue therapeutic. However, as result to lack of reliable toxicity data, the potential to affect human health still to be a major concern.The purpose of this literature review is to contribute to a better understanding of the principles and processes the science concepts on which nanobiotechnology meansandits applications in biomedicine will be discussed as well as to their side effects.

Licence https://creativecommons.org/licenses/by/4.0

System metadata — ISO 26324:2025, Annex B · DOI Handbook 10.1

Each element by the standard's name (Annex B: reference elements, then administrative) and the Handbook's (in grey), read off the record above.

ElementValueIn the record
DOI Name
DOI name
10.46243/jst.2021.v6.i2.pp01-08doi
Referent Type
referentType
Creationreferent
Referent Sub-Type
referentSubType
JournalArticle — an article in a journaltype
Referent Name(s)
referentName(s)
Review on Nanotechnology persecute vital role of Curative Applications in Medicinal Field and its ailing Effects (PrincipalTitle, en)titles
Basic Metadata
basicMetadata
author: Dr.A. Mohamed Sikkander
author: Dr.Khadeeja Yasmeen
publisher: Longman Publishers
published: 2021-02-02
part of: Journal of Science & Technology · ISSN 2456-5660 · vol. 06 · no. 02 · pp. 01–08
language: en
form: Digital · Visual · Language
agents, dates, container, language, structural_type, modes, characters
Referent Identifier(s)
alternateIdentifier(s)
none besides the DOIidentifiers, relations (IsSameAs)
Registration Authority
registrationAuthorityCode
Crossref — issued by Crossref (member 25296); held here as a copyrecord.source_agency (our code, ra_doi_name, for names issued here once appointed)
Created Date
issueDate
2026-09-10record.registered (when the DOI name was first registered)
relatedIdentifiersnone needed — the descriptive metadata is in this recordcontainer, relations (only where the descriptive metadata lives at another identifier)

complete Every System Metadata element is here, with the basic metadata a journal article needs.

The System Metadata Declaration (JSON) · the Kernel Metadata Declaration (XML) · what each sub-type needs

Cited by — in this registry

No record held in this registry cites this DOI.

Counts only records held in this registry; a citation from a work held elsewhere is not seen here. The list as JSON

References with DOIs

The record lists 60 references; 52 carry a DOI.

#ReferenceDOIHeld here
3ref3 Lewin R. (1987). National Academy looks at human genome.Science,Feb13;235(4790). 747-810.1126/science.3468626not held here
4ref4 Johnson, R. S. (1987). The human genome project: what impact on basic research?.The FASEB Journal,1(6), 502-50510.1096/fasebj.1.6.3479371not held here
5ref5 Yang, Z. R., & Hamer, R. (2007). Bio-basis function neural networks in protein data mining.Current pharmaceutical design, 13(14), 1403-141310.2174/138161207780765927not held here
6ref6 Ahrens, C. H., Wagner, U., Rehrauer, H. K., Türker, C., &Schlapbach, R. (2007). Current challenges and approaches for the synergistic use of systems biology data in the scientific…10.1007/978-3-7643-7439-6_12not held here
7ref7 ordan, B. R. (1999). ‘Genomics’: Buzzword or reality?Journal of biomedical science,6(3), 145-15010.1007/bf02255898not held here
8ref8 Weyant, R. G. (1967). Lycurgus: The father of applied psychology?American Psychologist,22(6), 43210.1037/h0021069not held here
10ref10 Logothetidis, S. (Ed.). (2012).Nanomedicine and nanobiotechnology. Springer Science & Business Media10.1007/978-3-642-24181-9not held here
11ref11 Bawa, R., Audette, G. F., & Rubinstein, I. (2016).Handbook of clinical nanomedicine: nanoparticles, imaging, therapy, and clinical applications. Pan Stanford10.1201/b19915not held here
12ref12 Hulla, J. E., Sahu, S. C., & Hayes, A. W. (2015). Nanotechnology: History and future.Human & experimental toxicology,34(12), 1318- 132110.1177/0960327115603588not held here
14ref14 Brown, E. M. B. (2014). Nanomedicine Advancements in Cancer Diagnosis and Treatment.Horizons in Clinical Nanomedicine, 6710.1201/b15666-4not held here
15ref15 Emerich DF. (2005).Nanomedicine-prospective therapeutic and diagnostic applied usages. Expert Opin. Biol. Ther, Jan;5(1). 1-510.1517/14712598.5.1.1not held here
16ref16 Avti, P. K., Patel, S. C., & Sitharaman, B. (2011). Nanobiomaterials: current status and future prospects.Nanobiomaterials handbook Edited by Balaji Sitharaman. CRC publication10.1201/b10970-2not held here
17ref17 Lee, L. A., & Wang, Q. (2006). Adaptations of nanoscale viruses and other protein cages for medical applications.Nanomedicine: Nanotechnology, Biology and Medicine,2(3), 137-14910.1016/j.nano.2006.07.009not held here
19ref19 Pauwels, E. K., &Erba, P. (2007). Towards the use of nanoparticles in cancer therapy and imaging.Drug news & perspectives,20(4), 213- 22010.1358/dnp.2007.20.4.1103525not held here
20ref20 Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005). Nanomedicine: current status and future prospects.The FASEB journal,19(3), 311-33010.1096/fj.04-2747revnot held here
21ref21 Gulati, N., & Gupta, H. (2012). Nanomedicine: Potential devices for diagnostics.Recent Patents on Nanomedicine,2(2), 146-155. 6 | Page Review on Nanotechnology persecute vital rol…10.2174/1877912311202020146not held here
23ref23 Dutta, R. C. (2007). Drug carriers in pharmaceutical design: promises and progress.Current pharmaceutical design,13(7), 761-76910.2174/138161207780249119not held here
24ref24 Dobson, J. (2006). Magnetic micro-and nano-particle-based targeting for drug and gene delivery.Nanomedicine10.2217/17435889.1.1.31not held here
25ref25 Freitas, R. A. (2005). Nanotechnology, nanomedicine and nanosurgery.International Journal of Surgery,4(3), 243-24610.1016/j.ijsu.2005.10.007not held here
26ref26 Ebbesen, M., & Jensen, T. G. (2006). Nanomedicine: techniques, potentials, and ethical implications.BioMed Research International,200610.1155/jbb/2006/51516not held here
27ref27 Fankhauser, F., Niederer, P. F., Kwasniewska, S., & van der Zypen, E. (2004). Supernormal vision, high-resolution retinal imaging, multiphoton imaging and nanosurgery of the corne…10.3233/thc-2004-12604not held here
28ref28 Lamounier, J. A., Moulin, Z. S., & Xavier, C. C. (2004). Recommendations for breastfeeding during maternal infections.Jornal de pediatria, 80(5), s181-s18810.2223/jped.1252not held here
29ref29 Iwaki, Y., Aiba, N., Tran, H. T. T., Ding, X., Hayashi, S., Arakawa, Y., & Abe, K. (2003). Simian TT virus (s-TTV) infection in patients with liver diseases.Hepatology research,25…10.1016/s1386-6346(02)00250-4not held here
31ref31 Filteau, S. M. (2000). Role of breast-feeding in managing malnutrition and infectious disease. Proceedings of the Nutrition Society, 59(4), 565-57210.1017/s002966510000080xnot held here
32ref32 Lawrence, R. M., & Lawrence, R. A. (2004). Breast milk and infection. Clinics in perinatology, 31(3), 501-52810.1016/j.clp.2004.03.019not held here
33ref33 Rajabi, M., Signorelli, P., Gorincioi, E., Ghidoni, R., &Santaniello, E. (2010). Antiproliferative activity of N 6-isopentenyladenosine on MCF-7 breast cancer cells: cell cycle an…10.1089/dna.2010.1073not held here
34ref34 Sahoo, S. K., &Labhasetwar, V. (2003). Nanotech approaches to drug delivery and imaging.Drug discovery today,8(24), 1112-112010.1016/s1359-6446(03)02903-9not held here
35ref35 Smith, D. J. (2007).Characterization of nanomaterials using transmission electron microscopy. The Royal Society of Chemistry: Cambridge.1-2710.1039/9781847557926-00001not held here
36ref36 Angeli, E., Buzio, R., Firpo, G., Magrassi, R., Mussi, V., Repetto, L., &Valbusa, U. (2008). Nanotechnology applications in medicine.Tumori Journal, 94(2), 206-21510.1177/030089160809400213not held here
37ref37 Rajabi, M., Srinivasan, M., & Mousa, S. A. (2016). Nanobiomaterials in drug delivery. In Nanobiomaterials in Drug Delivery. William Andrew Publishing. 1-3710.1016/b978-0-323-42866-8.00001-0not held here
38ref38 Allen, T. M., & Martin, F. J. (2004, December). Advantages of liposomal delivery systems for anthracyclines. InSeminars in oncology. WB Saunders. (31), 5-1510.1053/j.seminoncol.2004.08.001not held here
39ref39 Freitas Jr, R. A. (2000). Nanodentistry. The Journal of the American Dental Association, 131(11), 1559-156510.14219/jada.archive.2000.0084not held here
40ref40 Yao, J., Yang, M., &Duan, Y. (2014). Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnos…10.1021/cr200359pnot held here
41ref41 Shan, J., &Tenhu, H. (2007). Recent advances in polymer protected gold nanoparticles: synthesis, properties and applications.Chemical Communications, (44), 4580-459810.1039/b707740hnot held here
42ref42 Cai, W., Gao, T., Hong, H., & Sun, J. (2008). Applications of gold nanoparticles in cancer nanotechnology.Nanotechnology, science and applications, 1, 1710.2147/nsa.s3788not held here
43ref43 De Jong, W. H., &Borm, P. J. (2008). Drug delivery and nanoparticles: applications and hazards.International journal of nanomedicine,3(2), 13310.2147/ijn.s596not held here
44ref44 Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., &Medintz, I. L. (2013). Functionalizing nanoparticles with biological molecules: developing chemist…10.1021/cr300143vnot held here
45ref45 Gao, J., Huang, X., Liu, H., Zan, F., & Ren, J. (2012). Colloidal stability of gold nanoparticles modified with thiol compounds: bioconjugation and application in cancer cell imag…10.1021/la204289knot held here
46ref46 Alexis, F., Rhee, J. W., Richie, J. P., Radovic-Moreno, A. F., Langer, R., &Farokhzad, O. C. (2008, January). New frontiers in nanotechnology for cancer treatment. InUrologic Onco…10.1016/j.urolonc.2007.03.017not held here
47ref47 Loos, M. (2014). Carbon nanotube reinforced composites: CNT Polymer Science and Technology. Elsevier10.1016/b978-1-4557-3195-4.00002-3not held here
48ref48 Ju-Nam, Y and Lead, J.(2016). Properties, Sources, Pathways, and Fate of Nanoparticles in the Environment.Engineered Nanoparticles and the Environment: Biophysicochemical Processe…10.1002/9781119275855.ch6not held here
49ref49 Patra, C. R., Bhattacharya, R., Mukhopadhyay, D., & Mukherjee, P. (2010). Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Advanced drug delivery review…10.1016/j.addr.2009.11.007not held here
50ref50 Zhao, Y., Gu, X., Ma, H., He, X., Liu, M., & Ding, Y. (2011). Association of glutathione level and cytotoxicity of gold nanoparticles in lung cancer cells. The Journal of Physical…10.1021/jp2025413not held here
51ref51 Medley, C. D., Smith, J. E., Tang, Z., Wu, Y., Bamrungsap, S., & Tan, W. (2008). Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Analytical…10.1021/ac702037ynot held here
52ref52 Cheng, Y., Samia, A. C., Meyers, J. D., Panagopoulos, I., Fei, B., &Burda, C. (2008). Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therap…10.1021/ja801631cnot held here
54ref54 Morgan, K. (2005). Development of a preliminary framework for informing the risk analysis and risk management of nanoparticles.Risk Analysis: An International Journal, 25(6), 1621…10.1111/j.1539-6924.2005.00681.xnot held here
55ref55 Borm, P., Klaessig, F. C., Landry, T. D., Moudgil, B., Pauluhn, J., Thomas, K.,& Wood, S. (2006). Research strategies for safety evaluation of nanomaterials, part V: role of disso…10.1093/toxsci/kfj084not held here
56ref56 Balshaw, D. M., Philbert, M., & Suk, W. A. (2005). Research strategies for safety evaluation of nanomaterials, Part III: nanoscale technologies for assessing risk and improving pu…10.1093/toxsci/kfi312not held here
57ref57 Thomas, T., Thomas, K., Sadrieh, N., Savage, N., Adair, P., &Bronaugh, R. (2006). Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposur…10.1093/toxsci/kfj129not held here
58ref58 Love, S. A., Maurer-Jones, M. A., Thompson, J. W., Lin, Y. S., & Haynes, C. L. (2012). Assessing nanoparticle toxicity.Annual review of analytical chemistry,5, 181-20510.1146/annurev-anchem-062011-143134not held here
59ref59 Lee, S. Y., & Cheng, J. X. (2010). Clearance of nanoparticles during circulation.Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing, 1-3210.1002/9780470571224.pse496not held here
60ref60 Johnston, H. J., Semmler-Behnke, M., Brown, D. M., Kreyling, W., Tran, L., & Stone, V. (2010). Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary…10.1016/j.taap.2009.09.015not held here

The references as JSON

Relations

The record states no relation, and no record held here states one with this DOI.

The relations as JSON

Funding

The record names no funder.

Each funder's page lists every work held here that names it. ROR IDs open at ror.org; Funder Registry IDs resolve at doi.org.

History — the ledger

Every change to this DOI, in order, as it was recorded. Entries are only ever added, never changed or removed.

#WhenWhatByChanges
129 Sep 2026, 10:00 PMregister
registered at Crossref; record read from api.crossref.org
Administrator (admin) 231 fields set · sha256 d06f88034412…
229 Sep 2026, 11:59 PMupdate
record re-read from api.crossref.org
Administrator (admin)
container.titles.0.value: Journal of Science & Technology → Journal of Science & Technology

Machine-readable: the history as JSON, with the full record after each change.

Changes made at Crossref through DOI Doctor

Every deposit Smart Scholars' DOI Doctor made for this DOI, oldest first, with Crossref's own answer. Each fingerprint is the SHA-256 of its entry and of the fingerprint before it, so a change to any earlier entry changes every fingerprint after it.

WhenWhat changedCrossrefFingerprint
11 Sep 2026, 05:18Address updated
from https://www.jst.org.in/index.php/pub/article/view/356/314 to https://www.jst.org.in/index.php/pub/article/view/356
● accepted by Crossrefbdd6ba417353…
13 Sep 2026, 01:40Read back: the DOI resolves to the new address● confirmedab65b93f93e9…
15 Oct 2026, 15:30Metadata completed
abstract (199 words) · licence
● accepted by Crossref31e5500cae54…
15 Oct 2026, 16:19Read back: Crossref's record shows it● confirmed980c665ef007…

4 entries · the last fingerprint 980c665ef0075bcf4f0ed4f46ae5241be05ea497a98216582ee3a49585666511 · the history as JSON, each entry with the fingerprint before it, to check them yourself.

Share this page

Share this page

Ask AI about this page

Everything Smart Scholars runs

Nine sites, one account. A journal starts at the audit; an author starts at Scholar Shield.

What we do: DOIs registered from what a journal already has · Crossref records completed — references, abstracts, licences, ORCID iDs, affiliations and ROR IDs, funding · DOIs that resolve · articles preserved · journals rated on the public record · see everything we do →

Book a free call

For journals & publishers

Start with the audit — ₹4,999 per journal, and the gate to everything else.

DOI care

Every service on one journal profile — each previews first and acts only on your approval.

  • DOI Doctor — check & repairevery DOI tested at doi.org and Crossref; dead links, abstracts, licences, ORCIDs
  • Smart Deposita new DOI from your PDF, Word file, article page, JATS XML or spreadsheet — every value shown with its source, deposited once you confirm it
  • DOI census (Excel)site against Crossref, both directions, with a copy-paste fix per article
  • Backfile DOIsDOIs for older articles that never had one — no per-DOI fee of ours
  • DOIs for conference proceedingsthe conference, the volume and every paper — registered in the organiser's own name
  • Scopus indexing guidethe minimum criteria, the 14 CSAB criteria and how a title is suggested — from Elsevier's own page
  • Embase indexing guidewhat Embase asks of a biomedical journal and how to suggest it
  • Write DOIs into OJSthe verified DOIs pushed onto your article pages through your own API
  • Silent-failure monitorweekly checks of site, OAI-PMH, Scholar tags, ISSN, preservation, hijack lists
  • Journal Radarevery journal, every day: SSL, DNS, redirects, robots.txt, OJS, DOIs, Crossref metadata, broken links — what broke since yesterday first
  • Verified metrics & badgesa public, dated, source-linked metrics page and a "cited by" badge
  • Quality dossier (PDF)one PDF for universities, authors and reviewers
  • Author citation enginethe citation steps emailed to each author from the journal's own mailbox
  • JATS XMLmachine-readable JATS per article
  • Duplicate articlesthe same paper published twice — you choose which copy stays

For authors & researchers

Free to use. Nothing you check is shared with the journal.

For institutions, sponsors & DOI operators

Smart Scholars

Mon–Sat, 10:00–19:00 IST. The Ask AI button on every page answers about our services at any hour.

News

Policies

What we can register a DOI for

20 kinds of record, one account, one place. Every one gets a DOI that resolves, metadata that indexes read, and a record that stays correct afterwards.

Journals

  • Journal articles
  • Journal titles
  • Pending publications
  • Peer reviews
  • Preprints & posted content

Books & conferences

  • Books
  • Book chapters
  • Book series
  • Book sets
  • Conference proceedings
  • Proceedings series
  • Conference papers

Other research output

  • Theses & dissertations
  • Reports & working papers
  • Report series
  • Standards
  • Databases
  • Datasets
  • Figures, tables & supplements

Funding

  • Grants & funding awards

Elsewhere

The same company, in the places our publishers already read.
Add Smart Scholars as a preferred source on GoogleSee more of our newsroom in Google’s Top Stories.
Smart Scholars · Every service on one pageNewsroom posts CC BY 4.0 · DOI metadata CC0 · everything else ©Data from OpenAlex (openalex.org), CC0 · Crossref · ISSN Portal · DOAJContact
WhatsApp